McKesson Sells Minority Stake in Surgical Supplies Unit to Apollo for $1.25B

• Apollo Funds will acquire approximately 13% of the business through a convertible preferred equity investment valued at $1.25 billion
• The transaction values McKesson's medical-surgical solutions unit at roughly $13 billion total
• McKesson will retain majority ownership and control of the unit as it prepares for an independent IPO of the surgical instruments and services business

McKesson Sells Minority Stake in Surgical Supplies Unit to Apollo for $1.25B

Key Transaction Details:

McKesson Corporation announced on April 20 that it will sell approximately 13% of its medical-surgical solutions (MMS) business to Apollo Funds for $1.25 billion through a convertible preferred equity investment. The transaction values the entire MMS business at roughly $13 billion. McKesson will retain majority ownership and control of the unit.

Strategic Context:

This minority stake sale is part of McKesson's previously announced plan to spin off the medical-surgical solutions business through an initial public offering (IPO). The company disclosed last year its intention to separate the unit, which supplies surgical instruments and services, allowing McKesson to concentrate on its core drug distribution operations.

Business Rationale:

McKesson CEO Brian Tyler emphasized that Apollo's expertise in managing complex carve-out transactions and public market offerings will provide valuable support as the company positions MMS for independent success. The partnership appears designed to strengthen the unit ahead of its anticipated IPO.

Market Implications:

The deal represents a significant capital injection for McKesson while maintaining strategic control. The $13 billion valuation highlights the substantial value of the surgical supplies segment. For Apollo, this investment provides exposure to the healthcare supply chain sector with potential upside through the convertible preferred structure. The transaction reflects ongoing consolidation and optimization efforts within the healthcare distribution industry, as major players streamline operations to focus on core competencies. Investors should monitor the timing and terms of the eventual MMS IPO, which will complete McKesson's strategic repositioning.